SUN PHARMACEUTICAL IND L vs VIMTA LABS LIMITED
A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and VIMTA LABS LIMITED (VIMTALABS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
SUN PHARMACEUTICAL IND L vs VIMTA LABS LIMITED are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation22
- Profitability13
- Growth11
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
VIMTALABS takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
EvenThree-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
- + ["Company has reduced debt.", "Company is almost debt free.", "Company has delivered good profit growth of 30.0% CAGR over last 5 years"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.